What is CervoMed Inc.?
, a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood"brain barrier and inhibits the enzyme p38a. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 22.09M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 2100,000 shares $153k |
| 3-6months | 0 | 1955,414 shares $3.0M |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 0 |